Rita Nigam

522 total citations
17 papers, 359 citations indexed

About

Rita Nigam is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Rita Nigam has authored 17 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and 3 papers in Epidemiology. Recurrent topics in Rita Nigam's work include Immunotherapy and Immune Responses (8 papers), Nitric Oxide and Endothelin Effects (3 papers) and vaccines and immunoinformatics approaches (3 papers). Rita Nigam is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Nitric Oxide and Endothelin Effects (3 papers) and vaccines and immunoinformatics approaches (3 papers). Rita Nigam collaborates with scholars based in Canada, United States and Belgium. Rita Nigam's co-authors include Brian M. Bennett, W. Simon, Bernard McDonald, Jian‐Ping Jin, Chris R. Triggle, D J Anderson, Lisa D. MacDonald, Marianne M. Stanford, Mohan Karkada and Genevieve Weir and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Pharmacology and Experimental Therapeutics and Trends in Pharmacological Sciences.

In The Last Decade

Rita Nigam

17 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rita Nigam Canada	8	155	111	96	76	65	17	359
Paul A. Mieyal United States	9	73 0.5×	241 2.2×	174 1.8×	27 0.4×	30 0.5×	10	460
Stephen Eisennagel United States	8	126 0.8×	266 2.4×	50 0.5×	27 0.4×	41 0.6×	12	480
Takayuki Tanabe Japan	10	37 0.2×	157 1.4×	36 0.4×	36 0.5×	30 0.5×	44	445
Britta Landin Sweden	13	80 0.5×	190 1.7×	110 1.1×	18 0.2×	37 0.6×	31	514
Maria Theresa de Souza Accioly Brazil	7	29 0.2×	193 1.7×	147 1.5×	28 0.4×	9 0.1×	8	363
Anwar B. Bikhazi Lebanon	12	46 0.3×	112 1.0×	15 0.2×	20 0.3×	75 1.2×	51	350
Ermengilda McCauley United States	9	92 0.6×	117 1.1×	44 0.5×	104 1.4×	7 0.1×	11	382
Xiaohu Mei United States	12	113 0.7×	358 3.2×	41 0.4×	17 0.2×	48 0.7×	16	534
Antonio M. Gotto United States	11	52 0.3×	272 2.5×	62 0.6×	19 0.3×	86 1.3×	14	539
Alessia Francesca Mozzi Italy	9	61 0.4×	184 1.7×	41 0.4×	11 0.1×	12 0.2×	12	476

Countries citing papers authored by Rita Nigam

Since Specialization

Citations

This map shows the geographic impact of Rita Nigam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Nigam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Nigam more than expected).

Fields of papers citing papers by Rita Nigam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Nigam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Nigam. The network helps show where Rita Nigam may publish in the future.

Co-authorship network of co-authors of Rita Nigam

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Nigam. A scholar is included among the top collaborators of Rita Nigam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Nigam. Rita Nigam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Berinstein, Neil L., Matthew C. Cheung, Rena Buckstein, et al.. (2016). A phase 2 clinical trial testing DPX-Survivac and metronomic low dose cyclophosphamide as immunotherapy for patients with recurrent diffuse large b-cell lymphoma.. Journal of Clinical Oncology. 34(15_suppl). e14578–e14578. 3 indexed citations

Villella, Jeannine, Michelle Wilson, Neil L. Berinstein, et al.. (2016). Determination of optimal dose and treatment schedule of the immunotherapeutic vaccine, DPX-Survivac, for combination immunotherapy treatment of ovarian, fallopian tube or peritoneal cancer (OC): A phase Ib study.. Journal of Clinical Oncology. 34(15_suppl). e14577–e14577. 2 indexed citations

Feber, Andrew, Rita Nigam, Wei Shen Tan, et al.. (2015). 702 Epigenomics of penile squamous cell carcinoma. European Urology Supplements. 14(2). e702–e702a. 1 indexed citations

Villella, Jeannine, Michelle Wilson, Neil L. Berinstein, et al.. (2015). Safety, immunogenicity, and clinical activity of the immunotherapeutic vaccine, DPX-Survivac, in a Phase 1/1b trial of women with ovarian, fallopian tube, or peritoneal cancer.. Journal of Clinical Oncology. 33(15_suppl). 3072–3072. 3 indexed citations

Wilson, Michelle, Jeannine Villella, Neil L. Berinstein, et al.. (2014). Phase I/Ib clinical and immunologic assessment of immunotherapeutic vaccine, DPX-Survivac in women with ovarian, Fallopian tube, or peritoneal cancer (OC).. Journal of Clinical Oncology. 32(15_suppl). 5555–5555. 4 indexed citations

Berinstein, Neil L., Amit M. Oza, Kunle Odunsi, et al.. (2013). Effect of oral cyclophosphamide on the immunogenicity of DPX-Survivac in ovarian cancer patients: Results of a phase I study.. Journal of Clinical Oncology. 31(15_suppl). 3030–3030. 6 indexed citations

Berinstein, Neil L., Mohan Karkada, Michael A. Morse, et al.. (2012). First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients. Journal of Translational Medicine. 10(1). 156–156. 68 indexed citations

Berinstein, Neil L., Mohan Karkada, Rita Nigam, et al.. (2012). Effect of the novel therapeutic cancer vaccine formulation DPX-0907 on multifunctional T-cell responses in ovarian, breast, and prostate cancer patients.. Journal of Clinical Oncology. 30(15_suppl). 2588–2588. 1 indexed citations

Berinstein, N. L., Michael A. Morse, Howard L. Kaufman, et al.. (2011). A phase I study of the safety and immunogenicity of a therapeutic vaccine, DPX-0907 in patients with advanced-stage ovarian, breast, or prostate cancer.. Journal of Clinical Oncology. 29(15_suppl). e13050–e13050. 4 indexed citations

10.

Nigam, Rita, et al.. (2008). Development of Canadian Safety Indicators for Medication Use. Healthcare Quarterly. 11(sp). 47–53. 26 indexed citations

11.

Jin, Jian‐Ping, Di Wu, Jimin Gao, Rita Nigam, & Stephen M. Kwong. (2003). Expression and purification of the h1 and h2 isoforms of calponin. Protein Expression and Purification. 31(2). 231–239. 16 indexed citations

12.

Nigam, Rita, Jian‐Ping Jin, & Chris R. Triggle. (1998). h1- and h2-calponins are not essential for norepinephrine- or sodium fluoride-induced contraction of rat aortic smooth muscle. Journal of Muscle Research and Cell Motility. 19(6). 695–703. 31 indexed citations

13.

Nigam, Rita, et al.. (1996). Isoform-specific biotransformation of glyceryl trinitrate by rat aortic glutathione S-transferases.. Journal of Pharmacology and Experimental Therapeutics. 279(3). 1527–1534. 30 indexed citations

14.

Bennett, Brian M., Bernard McDonald, Rita Nigam, & W. Simon. (1994). Biotransformation of organic nitrates and vascular smooth muscle cell function. Trends in Pharmacological Sciences. 15(7). 245–249. 109 indexed citations

15.

Nigam, Rita, et al.. (1993). Effect of inhibitors of glutathione S-transferase on glyceryl trinitrate activity in isolated rat aorta. Canadian Journal of Physiology and Pharmacology. 71(2). 179–184. 17 indexed citations

16.

Nigam, Rita, et al.. (1992). Synthesis and Pharmacological Screening of some New 2-Thio-3-(substituted-aminomethyl)-5-(3,5-dinitrophenyl)-1,3,4-oxadiazoles. Zenodo (CERN European Organization for Nuclear Research). 3 indexed citations

17.

Bennett, Brian M., et al.. (1992). Inhibition of nitrovasodilator- and acetylcholine-induced relaxation and cyclic GMP accumulation by the cytochrome P-450 substrate, 7-ethoxyresorufin. Canadian Journal of Physiology and Pharmacology. 70(9). 1297–1303. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact